Giá hiện tại
ChemoCentryx, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of new drugs for inflammatory disorders, autoimmune diseases, and cancer in the United States. The company...|
e.g. Promoter holding
Loading chart...
Dự báo EPS và doanh thu theo đồng thuận của các nhà phân tích.
Dữ liệu dự báo lợi nhuận cho công ty này hiện không có.
| S.No. | Name | Symbol | Market Cap | P/E | P/B | Profit Margin | Op. Margin | ROE | Rev. Growth |
|---|---|---|---|---|---|---|---|---|---|
| 1. | BBain Capit... | BCSS | $598.60M | — | — | — | — | — | — |
| 2. | CChurchill... | CXII | $582.16M | — | — | — | — | — | — |
| 3. | CChurchill... | CCCX | $711.00M | — | 1.86 | — | — | — | — |
| 4. | CChurchill... | CCCX | $711.00M | — | 1.86 | — | — | — | — |
| 5. | AAmerican E... | AEXA | $533.68M | — | — | — | — | — | — |
Số liệu hợp nhất (triệu) / Có thể xem riêng lẻ
| Quarter (M) | Dec 21 | Mar 22 | Jun 22 | Jun 25 | Sep 25 | Dec 25 | Mar 26 | Jun 26 |
|---|---|---|---|---|---|---|---|---|
Revenue | 2.61 | 5.46 | 11.76 | 0 | 0 | 0 | 0 | 0 |
COGS | 0.3 | 0.2 | 0.8 | 0 | 0 | 0 | 0 | 0 |
Gross Profit | 2.31 | 5.25 | 10.96 | 0 | 0 | 0 | 0 | 0 |
Gross Profit % | 88.43% | 96.24% | 93.17% | - | - | - | - | - |
| 42.66 | 43.49 | 42.53 | 0.02 | 0.03 | 0.12 | 0.01 | 39.77 | |
EBIT | -40.05 | -38.23 | -31.57 | -0.02 | -0.05 | -0.12 | -0.01 | -39.77 |
OPM % | -1533.93% | -700.37% | -268.42% | - | - | - | - | - |
Non-Operating Income | -0.48 | -0.38 | -0.08 | 0 | 0 | 0 | 0.09 | 0 |
PBT | -40.53 | -38.61 | -31.65 | -0.02 | -0.05 | 0.43 | 0.08 | -134.68 |
Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Tax Rate % | - | - | - | - | - | - | - | - |
Net Income | -40.53 | -38.61 | -31.65 | -0.02 | -0.03 | 0.43 | 0.08 | -134.68 |
NPM % | -1552.2% | -707.24% | -269.07% | - | - | - | - | - |
Số liệu hợp nhất (triệu) / Có thể xem riêng lẻ
| Period (M) | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 6.06 | 0 | 0 | 11.44 | 82.5 | 42.88 | 35.95 | 64.89 | 32.22 | 0 |
COGS | 44.6 | 33.81 | 33.18 | 37.95 | 49.49 | 62.74 | 70.28 | 0 | 0.3 | 0 |
Gross Profit | 6.06 | -33.81 | -33.18 | 11.94 | 82.5 | 42.88 | 36.13 | 64.89 | 31.92 | 0 |
Gross Profit % | 100% | - | - | 104.37% | 100% | 100% | 100.49% | 100% | 99.06% | - |
| 45.17 | 47.4 | 47.69 | 52.16 | 66 | 83.14 | 94.25 | 120.07 | 162.14 | 0.17 | |
EBIT | -39.12 | -47.4 | -47.69 | -40.72 | 16.49 | -40.27 | -58.3 | -55.18 | -129.92 | -0.17 |
OPM % | -645.46% | - | - | -356.1% | 19.99% | -93.92% | -162.17% | -85.03% | -403.17% | - |
Non-Operating Income | 0.44 | 0.47 | 0.38 | 0.76 | 1.37 | 2.3 | 2.81 | -0.18 | -1.84 | 0 |
PBT | -38.67 | -46.93 | -47.3 | -39.96 | 17.86 | -37.97 | -55.49 | -55.36 | -131.75 | 0.38 |
Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Tax Rate % | 0% | 0% | 0% | 0% | 0% | 0% | - | - | - | - |
Net Income | -38.67 | -46.93 | -47.3 | -39.96 | 17.86 | -37.97 | -55.49 | -55.36 | -131.75 | 0.38 |
NPM % | -638.17% | - | - | -349.48% | 21.65% | -88.55% | -154.34% | -85.31% | -408.87% | - |
Số liệu hợp nhất (triệu) / Có thể xem riêng lẻ
| Period (M) | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| 10.26 | 16.07 | 12.82 | 12.02 | 40.02 | 28.09 | 39.18 | 32.3 | 49.98 | 0.74 | |
| 139.62 | 98.55 | 63.47 | 111.74 | 95.2 | 148.9 | 163.06 | 428.07 | 312.37 | 0 | |
| 1.4 | 1.21 | 0.95 | 0.91 | 1.21 | 1.54 | 2.15 | 25.16 | 32.27 | 0 | |
| 0.99 | 31.18 | 0.76 | 30.93 | 52.54 | 4.4 | 1.58 | 5 | 4.68 | 0.33 | |
| 0.16 | -30.02 | 0.16 | 0.28 | 0.36 | 0.39 | 3.11 | 28.37 | 26.35 | 414.85 | |
Total Assets | 152.42 | 116.98 | 78.16 | 155.87 | 189.33 | 183.31 | 209.08 | 518.9 | 425.65 | 415.91 |
| -145.26 | 0.04 | 0.04 | 0.05 | 0.05 | 0.05 | 0.06 | 0.07 | 0.07 | 414 | |
| 290.57 | 108.56 | 72.46 | 49.84 | 79.22 | 14.69 | 65.94 | 385.54 | 286.05 | -14.21 | |
| 0.33 | 0 | 0 | 0 | 91.95 | 168.59 | 21.29 | 63.92 | 23.64 | 0 | |
| 6.56 | 8.19 | 5.49 | 9.32 | 9.97 | 13.94 | 19.84 | 31.82 | 33.1 | 0.13 | |
| 0.23 | 0.18 | 0.15 | 96.67 | 8.14 | -13.95 | 101.96 | 37.55 | 82.79 | 15.99 | |
Total Liabilities | 152.42 | 116.98 | 78.16 | 155.87 | 189.33 | 183.31 | 209.08 | 518.9 | 425.65 | 415.91 |
Số liệu hợp nhất (triệu) / Có thể xem riêng lẻ
| Period (M) | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| -33.32 | -34.31 | -39.33 | 39.15 | 4.88 | 16.44 | -70.12 | -81.14 | -75.62 | -0.63 | |
| -31.67 | 38.34 | 33.88 | -48.76 | 15.6 | -53.07 | -12.53 | -282.36 | 92.22 | -414 | |
| 66.78 | 1.79 | 2.19 | 8.82 | 7.52 | 24.7 | 94.82 | 356.62 | 1.08 | 415.37 | |
Net CFNet Cash Flow | 1.8 | 5.82 | -3.25 | -0.8 | 28 | -11.93 | 12.17 | -6.88 | 17.68 | 0.74 |
FCFFree Cash Flow | -33.87 | -34.67 | -39.55 | 38.84 | 4.16 | 15.6 | -70.91 | -96.55 | -94.64 | -0.63 |
Financial ratios and valuation metrics by fiscal year.
| Period | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| -30.3% | -37.0% | -52.2% | -65.3% | 27.7% | -80.8% | -137.5% | -24.5% | -39.2% | 0.1% | |
| 0.00 | - | - | - | 1.16 | 11.44 | 0.32 | 0.17 | 0.08 | - | |
| 19.54 | 9.08 | 13.11 | 3.88 | 5.46 | 2.82 | 2.95 | 8.56 | 4.27 | 8.13 | |
| 0.04 | 0.00 | 0.00 | 0.10 | 0.48 | 0.23 | 0.18 | 0.18 | 0.07 | - | |
Cash Conversion | 0.86 | 0.73 | 0.83 | -0.98 | 0.27 | -0.43 | 1.26 | 1.47 | 0.57 | -1.66 |
Payout Ratio | - | - | - | - | 0.0% | - | - | - | - | - |
| 11.8% | -100.0% | - | - | 621.4% | -48.0% | -16.1% | 80.5% | -50.3% | - | |
| - | - | - | - | - | - | - | - | - | - | |
| - | - | - | - | - | - | - | - | - | - | |
| 4.00 | 3.00 | 3.00 | 5.00 | 5.00 | 2.00 | 2.00 | 2.00 | 2.00 | 4.00 | |
| -3.06 | - | - | - | 2.94 | -5.96 | 26.02 | -0.34 | 0.35 | - | |
| 66.67 | 0.00 | 0.00 | 50.00 | 60.00 | 33.33 | 60.00 | 66.67 | 66.67 | 0.00 | |
| -6.4% | - | - | -3.5% | 0.2% | -0.9% | -1.5% | -0.9% | -4.1% | - |
Note: These ratios and scores are calculated using publicly available financial data and may differ from other sources. Users are advised to verify calculations independently using SEC filings or other official sources before making investment decisions.
Ai sở hữu ChemoCentryx Inc, theo hồ sơ SEC
Chưa có hồ sơ sở hữu SEC cho công ty này.
Hồ sơ SEC và bản ghi cuộc gọi kết quả kinh doanh của ChemoCentryx Inc
Chưa có hồ sơ SEC cho công ty này.
What recent news says about ChemoCentryx Inc, scored for sentiment.